Life Scientist > Biotechnology

Human milk harnessed to administer medicine to infants

19 March, 2025

The Monash Milk Team are trailblazers in understanding how milk and milk-like systems can be harnessed to enhance oral drug delivery.


Tumour-invading protein delivers therapy straight to the brain

14 March, 2025

A protein called HER3, which is present on the blood–brain barrier, helps the tumour-invading protein cross from the bloodstream to the brain.


Success for Australia's first Total Artificial Heart implant

12 March, 2025

The recipient of the implant was discharged from hospital in February and received a donor transplant in March — 105 days after the procedure was performed.


Surface coating could prevent blood clots in medical implants

11 March, 2025

Zwitterions — a common macromolecule found in human cells — are being used to create materials that could stop blood clots from forming in medical devices like heart valves.


mRNA successfully delivered through blood–brain barrier

07 March, 2025

Getting mRNA into the brain could allow scientists to instruct brain cells to produce therapeutic proteins that can help treat or prevent disease.


Targeted therapy for childhood brain cancer shows promise

21 February, 2025

A potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumour cells in preclinical models.


TGA approves first treatment for geographic atrophy

07 February, 2025

Australia has become the first country outside of the United States to approve the use of the drug pegcetacoplan (SYFOVRE) to slow down the progression of geographic atrophy.


Specially designed peptides can treat complex diseases

06 February, 2025

Two separate research teams have found ways to create short chains of amino acids, termed peptides, for the purpose of treating a variety of diseases — including cancer.


New drug to prevent migraine claimed to work straight away

21 January, 2025

People taking atogepant showed improvement on assessments of how much migraine impaired their activities and their overall quality of life compared to people taking a placebo.


Targeting the stress system reduces Parkinson's tremors

16 January, 2025

The commonly used Parkinson's drug levodopa usually helps with tremors, but it tends to be less effective during stress, when tremors are often at their worst.


ADHD drug shows promise for treating meth addiction

13 January, 2025

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence.


Gene therapy reverses heart failure in large animal model

13 December, 2024

The therapy increases the amount of blood the heart can pump and dramatically improves survival, in an apparently unprecedented recovery of cardiac function.


A new way to cross the blood–brain barrier

04 December, 2024

The blood–brain barrier-crossing conjugate (BCC) system is designed to overcome the protective barrier that typically blocks large biomolecules from reaching the central nervous system.


Oxytocin analogue treats chronic abdominal pain

29 November, 2024

Researchers have developed a new class of oral painkillers to suppress chronic abdominal pain, based on the peptide hormone known as oxytocin.


Three-in-one pill could transform hypertension treatment

28 November, 2024

Australian research has produced impressive Phase III clinical trial results for an innovative combination of drugs, which could revolutionise the management of high blood pressure.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd